Research Focus

Former Employee. SKI Clinical Lab Services; Research Fellow

Recent additions – View all

1. Combining integrated genomics and functional genomics to dissect the biology of a cancer-associated, aberrant transcription factor, the ASPSCR1-TFE3 fusion oncoprotein

   Journal Article

   Kobos, R.; Nagai, M.; Tsuda, M.; Merl, M. Y.; Saito, T.; Lae, M.; Mo, Q.; Olshen, A.; Lianoglou, S.; Leslie, C.; more...
   Journal of Pathology (2013)

   Fulltext@MSK | Save
2. TFE3 fusions activate MET signaling by transcriptional up-regulation, defining another class of tumors as candidates for therapeutic MET inhibition

   Journal Article

   Tsuda, M.; Davis, I. J.; Argani, P.; Shukla, N.; McGill, G. G.; Nagai, M.; Saito, T.; Lae, M.; Fisher, D. E.; Ladanyi, M.
   Cancer Research (2007)

   Fulltext@MSK | Save
3. Activation of MET signaling by the aberrant transcription factor ASPL-TFE3 and its therapeutic inhibition by RNA interference

   Meeting Abstract

   Tsuda, M.; Nagai, M.; Saito, T.; Lae, M.; Ladanyi, M.
   Cancer Research (2006)

   Fulltext@MSK | Save